Affiliation:
1. Department of Allergy and Clinical Immunology National Research Institute for Child Health and Development Tokyo Japan
2. Center for Maternal‐Fetal Neonatal and Reproductive Medicine National Center for Child Health and Development Tokyo Japan
3. Allergy Center, National Center for Child Health and Development Tokyo Japan
4. Department of Obstetrics and Gynecology Dokkyo Medical University Tochigi Japan
Abstract
AbstractPreeclampsia is one of the most common disorders that poses threat to both mothers and neonates and a major contributor to perinatal morbidity and mortality worldwide. Viral infection during pregnancy is not typically considered to cause preeclampsia; however, syndromic nature of preeclampsia etiology and the immunomodulatory effects of viral infections suggest that microbes could trigger a subset of preeclampsia. Notably, SARS‐CoV‐2 infection is associated with an increased risk of preeclampsia. Herein, we review the potential role of viral infections in this great obstetrical syndrome. According to in vitro and in vivo experimental studies, viral infections can cause preeclampsia by introducing poor placentation, syncytiotrophoblast stress, and/or maternal systemic inflammation, which are all known to play a critical role in the development of preeclampsia. Moreover, clinical and experimental investigations have suggested a link between several viruses and the onset of preeclampsia via multiple pathways. However, the results of experimental and clinical research are not always consistent. Therefore, future studies should investigate the causal link between viral infections and preeclampsia to elucidate the mechanism behind this relationship and the etiology of preeclampsia itself.
Funder
Japan Health Research Promotion Bureau
Japan Society for the Promotion of Science
Nipponham Foundation
National Center for Child Health and Development